Absence of Alpha-synuclein MRNA Expression in Normal and Multiple System Atrophy Oligodendroglia

Overview

Journal J Neural Transm (Vienna)

Specialties Neurology
Physiology

Date 2005 Nov 15

PMID 16284907

Citations 98

Authors

D W Miller

J M Johnson

S M Solano

Z R Hollingsworth

D G Standaert

A B Young

Affiliations

Soon will be listed here.

Abstract

alpha-Synuclein is a major constituent of glial cytoplasmic inclusions (GCIs), which are pathognomic for multiple system atrophy (MSA). We have previously demonstrated that in normal human brain, alpha-synuclein mRNA has a restricted pattern of neuronal expression and no apparent glial expression. The current study used double-label in situ hybridization to determine if alpha-synuclein mRNA is expressed by oligodendroglia of MSA cases. Analysis of MSA brain tissue revealed depletion of regional signal for this transcript in many brain areas due to extensive neurodegeneration. Cellular analysis of oligodendroglia in crus cerebri, a GCI-rich region ventral to substantia nigra, revealed an absence of alpha-synuclein mRNA signal in control and MSA cases. However, an abundance of this transcript was detected in melanin-containing neurons of substantia nigra. Therefore, oligodendroglia do not express alpha-synuclein mRNA in control and MSA cases suggesting that involvement of alpha-synuclein in GCI pathology of MSA is due to its ectopic presence in oligodendroglia.

Citing Articles

Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research.

Szegvari E, Holec S, Woerman A J Neurochem. 2025; 169(3):e70021.

PMID: 40026260 PMC: 11874209. DOI: 10.1111/jnc.70021.

Imaging spatial transcriptomics reveals molecular patterns of vulnerability to pathology in a transgenic α-synucleinopathy model.

Horan-Portelance L, Iba M, Acri D, Gibbs J, Cookson M bioRxiv. 2024; .

PMID: 39372781 PMC: 11451628. DOI: 10.1101/2024.07.31.606032.

Comparing alpha-synuclein-interactomes between multiple systems atrophy and Parkinson's disease reveals unique and shared pathological features.

Choi S, Tittle T, Barot R, Betts D, Gallagher J, Kordower J bioRxiv. 2024; .

PMID: 39345456 PMC: 11429994. DOI: 10.1101/2024.09.20.613717.

Navigating through the complexities of synucleinopathies: Insights into pathogenesis, heterogeneity, and future perspectives.

Lazaro D, Lee V Neuron. 2024; 112(18):3029-3042.

PMID: 38861985 PMC: 11427175. DOI: 10.1016/j.neuron.2024.05.017.

A novel mouse model for investigating α-synuclein aggregates in oligodendrocytes: implications for the glial cytoplasmic inclusions in multiple system atrophy.

Ishimoto T, Oono M, Kaji S, Ayaki T, Nishida K, Funakawa I Mol Brain. 2024; 17(1):28.

PMID: 38790036 PMC: 11127389. DOI: 10.1186/s13041-024-01104-7.

References

Kahle P, Neumann M, Ozmen L, Muller V, Jacobsen H, Spooren W . Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep. 2002; 3(6):583-8. PMC: 1084143. DOI: 10.1093/embo-reports/kvf109. View

El-Agnaf O, Salem S, Paleologou K, Cooper L, Fullwood N, Gibson M . Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J. 2003; 17(13):1945-7. DOI: 10.1096/fj.03-0098fje. View

Nakamura S, Kawamoto Y, Nakano S, Akiguchi I . Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy. Clin Neuropathol. 2000; 19(2):51-6. View

Jellinger K, Seppi K, Wenning G . Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord. 2005; 20 Suppl 12:S29-36. DOI: 10.1002/mds.20537. View

Richter-Landsberg C, Gorath M, Trojanowski J, Lee V . alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes. J Neurosci Res. 2000; 62(1):9-14. DOI: 10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U. View

Counihan T, Landwehrmeyer G, Standaert D, Kosinski C, Scherzer C, Daggett L . Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons. J Comp Neurol. 1998; 390(1):91-101. View

Papp M, Kahn J, Lantos P . Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci. 1989; 94(1-3):79-100. DOI: 10.1016/0022-510x(89)90219-0. View

Nakamura S, Kawamoto Y, Nakano S, Akiguchi I, Kimura J . Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy. J Neuropathol Exp Neurol. 1998; 57(7):690-8. DOI: 10.1097/00005072-199807000-00006. View

Miller D, Hague S, Clarimon J, Baptista M, Gwinn-Hardy K, Cookson M . Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology. 2004; 62(10):1835-8. DOI: 10.1212/01.wnl.0000127517.33208.f4. View

10.

Borghi R, Marchese R, Negro A, Marinelli L, Forloni G, Zaccheo D . Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci Lett. 2000; 287(1):65-7. DOI: 10.1016/s0304-3940(00)01153-8. View

11.

Maroteaux L, Campanelli J, Scheller R . Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci. 1988; 8(8):2804-15. PMC: 6569395. View

12.

Sung J, Kim J, Paik S, Park J, Ahn Y, Chung K . Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein. J Biol Chem. 2001; 276(29):27441-8. DOI: 10.1074/jbc.M101318200. View

13.

Arima K, Ueda K, Sunohara N, Arakawa K, Hirai S, Nakamura M . NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. 1998; 96(5):439-44. DOI: 10.1007/s004010050917. View

14.

Yazawa I, Giasson B, Sasaki R, Zhang B, Joyce S, Uryu K . Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron. 2005; 45(6):847-59. DOI: 10.1016/j.neuron.2005.01.032. View

15.

Honjyo Y, Kawamoto Y, Nakamura S, Nakano S, Akiguchi I . P39 immunoreactivity in glial cytoplasmic inclusions in brains with multiple system atrophy. Acta Neuropathol. 2001; 101(3):190-4. DOI: 10.1007/s004010000246. View

16.

Ozawa T, Okuizumi K, Ikeuchi T, Wakabayashi K, Takahashi H, Tsuji S . Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol. 2001; 102(2):188-90. DOI: 10.1007/s004010100367. View

17.

Singleton A, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J . alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003; 302(5646):841. DOI: 10.1126/science.1090278. View

18.

Miller D, Cookson M, Dickson D . Glial cell inclusions and the pathogenesis of neurodegenerative diseases. Neuron Glia Biol. 2006; 1(1):13-21. PMC: 1435946. DOI: 10.1017/s1740925x04000043. View

19.

Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva H . The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995; 14(2):467-75. DOI: 10.1016/0896-6273(95)90302-x. View

20.

KERNER J, Standaert D, Penney Jr J, Young A, Landwehrmeyer G . Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes. Brain Res Brain Res Protoc. 1998; 3(1):22-32. DOI: 10.1016/s1385-299x(98)00017-8. View